CapsulesClinical Overview
Rabeprazole Sodium (20mg enteric-coated) and Levosulpiride (75mg sustained-release) combines a fast-acting proton pump inhibitor with a prokinetic and psychotropic benzamide. Rabeprazole rapidly suppresses gastric acid output, while levosulpiride selectively blocks dopamine D2 receptors and activates 5-HT4 receptors in the gastrointestinal tract, stimulating gastroduodenal motility and improving visceral hypersensitivity. Indicated for severe GERD, reflux esophagitis with delayed gastric emptying, non-ulcer dyspepsia, and gastroparesis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally once daily in the morning before breakfast. Swallow whole with water; do not crush or chew.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, fatigue, amenorrhea, breast engorgement/galactorrhea, gynecomastia, diarrhea, flatulence. Rare/Severe: Extrapyramidal symptoms (tremors, acute dystonia), neuroleptic malignant syndrome, and severe hyperprolactinemia.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in GI bleeding, mechanical bowel obstruction, pheochromocytoma, and epilepsy. Levosulpiride should not be used long-term without periodic neurological reassessment due to tardive dyskinesia risk. Avoid alcohol and sedatives.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Dicyclomine Tablets 10mg
Dicyclomine Hydrochloride Tablets (10mg) is an oral synthetic tertiary amine antispasmodic. It possesses specific anticholinergic (antimuscarinic) and direct musculotropic relaxant effects on gastrointestinal smooth muscle, eliminating visceral spasms and hypermotility. Indicated for irritable bowel syndrome (IBS), functional enterospasm, and abdominal cramping.
Paracetamol 325mg + Dicyclomine Hydrochloride 20mg Tablets
Paracetamol (325mg) and Dicyclomine Hydrochloride (20mg) Tablets is a fixed-dose antispasmodic and analgesic combination. Dicyclomine blocks muscarinic M1/M3 receptors on smooth muscle and produces direct musculotropic relaxation of the gastrointestinal and biliary tracts. Paracetamol provides centrally acting pain relief. Indicated for spasmodic abdominal pain, intestinal colic, biliary colic, renal colic, and painful dysmenorrhea.
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Dicyclomine Hydrochloride 10mg + Mefenamic Acid 250mg Tablets
Dicyclomine Hydrochloride (10mg) and Mefenamic Acid (250mg) Tablets is a fixed-dose antispasmodic and fenamate NSAID combination. Dicyclomine relieves visceral smooth muscle spasms via antimuscarinic action and direct musculotropic relaxation; mefenamic acid inhibits cyclooxygenase and antagonizes prostaglandin receptors, eliminating pelvic pain and cramping. Indicated for severe spasmodic dysmenorrhea, intestinal colic, and spastic abdominal pain.